08-Jan-2024
2 mins read
The Rights Issue Committee of Genpharmasec Limited decided that Tuesday, January 9, 2024, will be the key date to determine the shareholders eligible to apply for the Rights Equity Shares. They also announced the timeline for the Rights Issue, which will commence on January 22, 2024, and conclude on February 9, 2024. The price for each Rights Equity Share has been set at Rs 1.75, with the total issue size amounting to Rs. 4845.05 Lakhs. The allocation ratio is 1:1, meaning eligible shareholders can acquire one Equity Share for every share they possess as of the record date. Applicants are required to pay the full amount of Rs. 1.75 per Equity Share at the time of application.
In trading news, the shares of GenPharmasec Ltd were last seen on the BSE at a trading price of Rs 4.78, showing a minor increase from its previous closing price of Rs 4.76. The day witnessed a trading volume of 481,150 shares across 1616 trades, with the stock reaching a peak of Rs 4.80 and a low of Rs 4.75. The total trading turnover for the day was reported to be Rs 2299530.00.
Genpharmasec Ltd Rights Issue Company Profile
Founded in 1992, Generic Pharmasec Limited originally produced and traded various chemicals, including organic and inorganic chemicals, dyes, and pigments. However, the company shifted its focus in 2018 towards purchasing, selling, and distributing a range of pharmaceutical and medicinal products. The company has recently made a strategic move into the securities market.
Generic Pharmasec Limited has collaborated with Abbott Point of Care Corporation INC, based in the USA, to distribute their cutting-edge diagnostic tool, the i-STAT 1 Analyser. This device is primarily utilised in Intensive Care Units (ICUs) and Cardiac Care Units (CCUs) of hospitals for rapid testing results. The i-STAT 1 Analyser is known for its portability, user-friendliness, and lightweight design. It functions using the innovative technology of i-STAT test cartridges. Together, these components constitute the i-STAT system, a critical point-of-care testing platform that offers timely and essential diagnostic data to healthcare professionals right where it is needed.
Genpharmasec Ltd Financial Information
Between the fiscal years ending March 31, 2023, and March 31, 2022, Genpharmasec Ltd experienced a 6.56% decline in revenue, while its profit after tax (PAT) saw a significant increase of 637.15%.
| Period Ended | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 |
| Assets | 19.88 | 21.65 | 27.82 |
| Revenue | 25.62 | 27.41 | 21.64 |
| Profit After Tax | 1.12 | -0.21 | 1.26 |
| Net Worth | |||
| Reserves and Surplus | 28.78 | 28.99 | |
| Total Borrowing |
Important Details of Genpharmasec Ltd Rights Issue
| Issue Open | January 22, 2024 – February 9, 2024 |
| Security Name | Genpharmasec Ltd |
| Issue Size (Shares) | Yet to be announced |
| Issue Size (Amount) | Rs 48.45 Crores |
| Issue Price | Rs 1.75 per share |
| Face Value | Re 1 per share |
| Listing At | BSE |
| Terms of Payment | Full amount of Rs 1.75 per Equity Share is payable on application. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date |
Tentative Timetable of Genpharmasec Ltd Rights Issue 2024
| Last Date to buy shares | 8-Jan-24 |
| Record Date | 9-Jan-24 |
| Credit of Rights Entitlements | Yet to be announced |
| Bid/Offer Opens On | 22-Jan-24 |
| Renunciation of Rights Entitlements | 2-Feb-24 |
| Bid/Offer Closes On | 9-Feb-24 |
| Deemed Date of Allotment | Yet to be announced |
| Credit Date | Yet to be announced |
| Listing Date | Yet to be announced |
Purpose of the Issue
The purpose of Genpharmasec Ltd Rights Issue 2024 is yet to be announced.
How to Apply for Genpharmasec Ltd Rights Issue 2024
Wait for the public issue to open for subscription, then click on this link to apply for the Genpharmasec Ltd Rights Issue 2024 with Bigul https://www.bonanzaonline.com/.
How to Check Allotment Status
The registrar for Genpharmasec Ltd Rights Issue 2024 is yet to be announced. To check your allotment status, please stay tuned with Bigul.
FAQs
- What is the record date for the Genpharmasec Ltd Rights Issue 2024?
The record date to determine the eligible shareholders for the Genpharmasec Ltd Rights Issue is January 9, 2024. Shareholders who own shares as of this date will be eligible to apply for the Rights Equity Shares.
- What are the opening and closing dates for this Rights Issue?
The Rights Issue will open on January 22, 2024, and close on February 9, 2024. This period is when eligible shareholders can apply for the Rights Equity Shares.
- What is the issue price for the Genpharmasec Ltd Rights Equity Shares?
The issue price for the Rights Equity Shares has been set at Rs 1.75 per share. The full amount is payable upon application.
- How can I apply for the Genpharmasec Ltd Rights Issue 2024?
Once the public issue opens for subscription, you can apply for the Genpharmasec Ltd Rights Issue 2024 by visiting this link: https://www.bonanzaonline.com/. Make sure you are eligible and have the shares in your account by the record date.
- How do I check the allotment status for the Genpharmasec Ltd Rights Issue 2024?
The registrar for the Rights Issue is yet to be announced. To check your allotment status, you should stay updated with Bigul once the issue is closed and the allotment process begins.